John Celebi

Insider Reports History

Location
Rockville, MD
Signature
/s/ Mark Ballantyne, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by John Celebi:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Sensei Biotherapeutics, Inc. PRESIDENT AND CEO, Director Common Stock 106K $50.4K $0.48 19 Feb 2025 Direct
Sensei Biotherapeutics, Inc. PRESIDENT AND CEO, Director Stock Option (Right to Buy) 360K 14 Feb 2025 Direct

Insider Reports Filed by John Celebi

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SNSE Sensei Biotherapeutics, Inc. 19 Feb 2025 1 -$2.65K 4 PRESIDENT AND CEO, Director 26 Feb 2025, 18:45
SNSE Sensei Biotherapeutics, Inc. 14 Feb 2025 1 $0 4 PRESIDENT AND CEO, Director 14 Feb 2025, 18:03
SNSE Sensei Biotherapeutics, Inc. 20 Dec 2024 1 $0 4 PRESIDENT AND CEO, Director 23 Dec 2024, 16:15
SNSE Sensei Biotherapeutics, Inc. 15 Feb 2024 3 -$4.65K 4 PRESIDENT AND CEO, Director 16 Feb 2024, 18:28
SNSE Sensei Biotherapeutics, Inc. 11 Sep 2023 1 $425 4 President and CEO, Director 13 Sep 2023, 09:43
SNSE Sensei Biotherapeutics, Inc. 15 Feb 2023 1 -$30.7K 4 President and CEO, Director 11 Sep 2023, 18:33
SNSE Sensei Biotherapeutics, Inc. 15 Feb 2023 3 $0 4/A President and CEO, Director 29 Mar 2023, 17:16
SNSE Sensei Biotherapeutics, Inc. 15 Feb 2022 2 $0 4 President and CEO, Director 17 Feb 2022, 17:20